telotristat ethyl

FDA Drug Profile — Xermelo

Drug Details

Generic Name
telotristat ethyl
Brand Names
Xermelo
Application Number
NDA208794
Sponsor
Lexicon Pharmaceuticals, Inc.
NDC Codes
4
Dosage Forms
TABLET
Routes
ORAL
Active Ingredients
TELOTRISTAT ETHYL

Indications and Usage

1 INDICATIONS AND USAGE Xermelo is indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. Xermelo is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. ( 1 )